In this review article, we embark on a thorough exploration of cannabinoids, compounds that
have garnered considerable attention for their potential therapeutic applications. Initially, this …

Cannabinoid use has surged in the past decade, with a growing interest in expanding
cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) applications into special …

Understanding cannabis‐drug interactions is critical given regulatory changes that have
increased access to and use of cannabis. Cannabidiol (CBD) and Δ‐9 …

Background and objective: Commercially available cannabidiol (CBD) products are
increasingly being used for medicinal purposes, including for the treatment of various …

Background Cannabis contains hundreds of chemical constituents beyond delta-9-
tetrahydrocannabinol (THC), which is believed to drive most of its acute pharmacodynamic …

Cannabidiol (CBD) is widely used and believed to be non-intoxicating, lacking acute
performance effects (eg, non-impairing). However, a synthesis of data has not evaluated …

Cannabidiol (CBD)-containing products are widely marketed as over the counter products.
Adverse effects reported in anecdotal consumer reports or during clinical studies were first …

Simple Summary It is easy to find success stories on the internet of patients with cancer who
seem to benefit from using cannabis products. However, scientific substantiation is usually …

The legalization of cannabis in Canada has accelerated the need for a standardized
approach to measuring and communicating the amount of delta-9-tetrahydrocannabinol …

Introduction: Minor cannabinoids are increasingly being consumed in oral formulations (ie,
edibles, tinctures) for medical and nonmedical purposes. This study examined the …